Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Research into Oral Semaglutide and Heart Failure Outcomes
February 2026
The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.
Read more
5
Mins
18 Sep 2023
ESC 2023 Interview: Nina Ajmone Marsan
During my training in Cardiology, I quickly developed a passion for imaging, as it provides every cardiologist the tool…
8 Sep 2023
Elevated Sedentary Time in Childhood Linked to Enlarged Heart
Childhood sedentary behaviour has been linked to likelihood of experiencing an increase in left ventricular mass as young adults…
8 Sep 2023
Modifiable Risk Factors Linked to >50% of Cardiovascular Disease Cases
According to research, over 50% of cardiovascular disease cases can be linked to five adjustable risk factors. Read for details…
21 Aug 2023
Introducing Mavacamten for the Treatment of NYHA Class II and III Symptomatic Obstructive HCM in Adult Patients
This infographic explores mavacamten, the first cardiac myosin inhibitor for New York Heart Association (NYHA) Class II and III…
12
Mins
15 Aug 2023
Diagnosing Fabry Disease: Practical Clinical Recommendations and Guidance for Patients with Fabry Disease
This article was funded by Sanofi and is intended for healthcare professionals.
3 Aug 2023
Low Referral and Utilisation of Cardiac Rehabilitation in Patients with Heart Failure
Researchers studied cardiac rehabilitation referral and utilization among patients with heart failure and reduced ejection fraction…
3 Aug 2023
Improved Outcomes in Transcatheter Aortic Valve Replacement Compared to Surgery
A research suggests transcatheter aortic valve replacement to be better than surgery for patients with obesity and severe aortic stenosis…
12 Jul 2023
Are Myosin Inhibitors the Future of HCM Management?
This podcast episode explores new advances in treating obstructive hypertrophic cardiomyopathy (HCM) and the role of myosin inhibitors.
Loading posts...
« Previous
1
…
40
41
42
43
44
…
96
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View